Kiyonori Miura
Overview
Explore the profile of Kiyonori Miura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hiraga K, Tezuka K, Nagata K, Koh K, Nakamura H, Sagara Y, et al.
J Virol Methods
. 2024 Nov;
332:115071.
PMID: 39577671
The human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, integrates into host DNA and causes adult T-cell leukemia/lymphoma (ATL) in some individuals. Two types of defective proviruses, Type 1...
2.
Sagara Y, Nakamura H, Sagara Y, Shitsuta E, Uchimaru K, Yamano Y, et al.
J Med Virol
. 2024 Sep;
96(9):e29898.
PMID: 39221490
The active form of vitamin D (VD) exerts hormonal effects by regulating the expression of genes involved in T-cell activity, cell differentiation, and proliferation. Human T-cell leukemia virus type 1...
3.
Ito Y, Morioka I, Takahashi N, Fujioka K, Miura K, Moriuchi H, et al.
Pediatr Infect Dis J
. 2024 Jul;
43(11):e390-e396.
PMID: 39079035
Congenital cytomegalovirus (cCMV) infection is the most common congenital infection in developed countries. Although a standard therapy has not yet been established, evidence for the management of cCMV infection has...
4.
Itamochi H, Takeshima N, Hamanishi J, Hasegawa K, Matsuura M, Miura K, et al.
J Gynecol Oncol
. 2024 Jul;
35(5):e115.
PMID: 39058367
Objective: This study evaluated the long-term safety and efficacy of niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer. Methods: This was a follow-up analysis of a phase 2, multicenter,...
5.
Ueda A, Nakai H, Miyagawa C, Otani T, Yoshida M, Murakami R, et al.
Am J Pathol
. 2024 Jul;
194(10):1913-1923.
PMID: 39032605
Four subtypes of ovarian high-grade serous carcinoma (HGSC) have previously been identified, each with different prognoses and drug sensitivities. However, the accuracy of classification depended on the assessor's experience. This...
6.
Nakano S, Koide S, Hosaka Y, Hasegawa Y, Ishida-Kuroki K, Kawakami S, et al.
J Med Microbiol
. 2024 Jul;
73(7).
PMID: 38985141
Maternal screening tests and prophylactic antibiotics are important to prevent neonatal and infant group B streptococcal (GBS) infections. The performance of enrichment broth media for GBS screening that are available...
7.
Araki H, Sekino M, Hasegawa Y, Kurobe M, Motokawa T, Tanigawa A, et al.
Medicine (Baltimore)
. 2024 May;
103(20):e38176.
PMID: 38758915
Rationale: Amniotic fluid embolism (AFE) is a fatal obstetric condition that often rapidly leads to severe respiratory and circulatory failure. It is complicated by obstetric disseminated intravascular coagulation (DIC) with...
8.
Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I, et al.
J Virol
. 2024 Jan;
98(2):e0186223.
PMID: 38294250
The primary mode of infection by human T-cell leukemia virus type 1 (HTLV-1) is cell-to-cell transmission during contact between infected cells and target cells. Cell-free HTLV-1 infections are known to...
9.
Kuramitsu M, Momose H, Uchida Y, Ishitsuka K, Kubota R, Tokunaga M, et al.
Microbiol Spectr
. 2023 Nov;
11(6):e0207823.
PMID: 37966220
The World Health Organization estimated that 5-10 million people are infected with human T-cell leukemia virus type 1 (HTLV-1). This number is likely to be underestimated because reliable endemic data...
10.
Tanaka A, Matsumoto M, Takao M, Miura S, Hasegawa Y, Otsubo R, et al.
Hered Cancer Clin Pract
. 2023 Nov;
21(1):23.
PMID: 37957733
Background: In Japan, genetic testing, surveillance, and risk-reducing surgery for hereditary breast and ovarian cancer (HBOC) syndrome have been covered by the Japanese national insurance system since April 2020. On...